Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ante Strikic"'
Autor:
Ante Strikic, Josipa Kokeza, Marin Ogorevc, Nela Kelam, Martina Vukoja, Petar Dolonga, Sandra Zekic Tomas
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Renal cell carcinoma (RCC) represents around 3% of all cancers, with the most frequent histological types being clear-cell RCC (ccRCC), followed by papillary (pRCC) and chromophobe (chRCC). Hypoxia-inducible factors (HIFs), which promote the expressi
Externí odkaz:
https://doaj.org/article/c1d3b3e191174da2881012fa4c455f28
Autor:
Josipa Kokeza, Ante Strikic, Marin Ogorevc, Nela Kelam, Martina Vukoja, Ivo Dilber, Sandra Zekic Tomas
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 13, p 10575 (2023)
Lung cancer is the second-most-common cancer while being the leading cause of cancer deaths worldwide. It has been found that glucose transporter 1 (GLUT1) and hypoxia-inducible factor 1α (HIF-1α) are overexpressed in various malignancies and that
Externí odkaz:
https://doaj.org/article/7b7cb9ac171749d3b385ccd980e54ca1
Autor:
Tomas, Josipa Kokeza, Ante Strikic, Marin Ogorevc, Nela Kelam, Martina Vukoja, Ivo Dilber, Sandra Zekic
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 13; Pages: 10575
Lung cancer is the second-most-common cancer while being the leading cause of cancer deaths worldwide. It has been found that glucose transporter 1 (GLUT1) and hypoxia-inducible factor 1α (HIF-1α) are overexpressed in various malignancies and that
Publikováno v:
Biomed Rep
The aim of the present study was to compare the immunohistochemical expression of glucose transporter 1 (GLUT1) between the most common histological types of renal cell carcinoma (RCC), and to determine whether a correlation between GLUT1 expression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ab85702adc7f2bdc77790d778437412
https://www.bib.irb.hr/1222012
https://www.bib.irb.hr/1222012
Publikováno v:
Anticancer research. 35(7)
The standard treatment for locally advanced cervical cancer (LACC) is concomitant chemoradiotherapy. In the majority of patients with LACC after properly executed concomitant chemoradiotherapy local control of the disease is achieved, and consequentl